Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Trial in progress: A phase 1b, open-label, multiple ascending dose study of OM336, a novel BCMAxCD3 T cell engager, in patients with relapsed/refractory autoimmune cytopenias (NCT07083960)

Catherine Broome, Danny Hsu, Philip Choi, Charlie Zhou, Neelufar Mozaffarian

Blood (2025) 146 (Supplement 1): 2900.

https://doi.org/10.1182/blood-2025-2900

Published: 2025

Journal Articles

Long-term efficacy and safety of rilzabrutinib, an oral bruton tyrosine kinase (BTK) inhibitor in patients with warm autoimmune hemolytic anemia (wAIHA) in the LUMINA Phase 2b part B study: A 74-week follow-up

Bruno Fattizzo, Henrik Frederiksen, Alessandro Lucchesi, Bing Han, Catherine Broome, Nicola Cooper, Joan Cid, Frederick Chen, Amitabha Mazumder, Míriam Vara Pampliega, Deepthi Jayawardene, Heidi Krenz, Jing Zhao, Ahmed Daak, David Kuter

Blood (2025) 146 (Supplement 1): 4655.

https://doi.org/10.1182/blood-2025-4655

Published: 2025

Journal Articles

The safety and efficacy of pirtobrutinib in adults with immune thrombocytopenia: A phase 1/2 dose-finding study in progress

Catherine Broome, Tomas Jose Gonzalez-Lopez, Ananya Guntur, Chunxiao Wang, Sasha Amdur, James Pauff, Waleed Ghanima

Blood (2025) 146 (Supplement 1): 8231.

https://doi.org/10.1182/blood-2025-8231

Published: 2025

Journal Articles

Sustained improvements in patient-reported outcomes after intravenous efgartigimod in adults with primary immune thrombocytopenia in a Phase 3 clinical trial (ADVANCE IV) and the first 52 weeks in its open-label extension study (ADVANCE IV+)

Monica Carpenedo, Catherine Broome, Blanca Sánchez González, Vickie McDonald, Yoshitaka Miyakawa, Kaichi Nishiwaki, Francesco Zaja, Hanny Al-Samkari, Filip Matthijssens, Damien Chimits, Jaume Ayguasanosa, Syed Raza, Giles Monnickendam, Francesco Rodeghiero, Marc Michel, Adrian Newland

Blood (2025) 146 (Supplement 1): 6245.

https://doi.org/10.1182/blood-2025-6245

Published: 2025

Journal Articles

Survival outcomes of patients with secondary hemophagocytic lymphohistiocytosis at two academic medical centers in the United States

Catherine Broome, Daniel Hausrath, Jim Jaworski, Stephen Fernandez, Todd Edwards, Joseph Catlett, Rahul Shah, Elaine Xie, Steve Moore, Kathy Dong, Kim-Hien Dao, Kelly Covert, Lauren Bylsma, Michael Kelsh, Loren Lipworth, Meghan Mitchell

Blood (2025) 146 (Supplement 1): 6243.

https://doi.org/10.1182/blood-2025-6243

Published: 2025

Journal Articles

Real-world safety of sutimlimab in patients with CAD/CAS: A multinational, multi-center, observational, prospective cohort Study

Alexander Röth, Marc Michel, Wilma Barcellini, Ulrich Jaeger, Yasutaka Ueda, Quentin A. Hill, Joan Cid, Kelley Dacus, Mounia Beloueche, Catherine Broome

Blood (2025) 146 (Supplement 1): 6242.

https://doi.org/10.1182/blood-2025-6242

Published: 2025

Journal Articles

Initial Report of Povetacicept, an Enhanced Dual BAFF/APRIL Antagonist, in Autoimmune Cytopenias: The RUBY-4 Study

Catherine Broome, David J Kuter, Keith R. McCrae, Rupert Davies, Amanda Enstrom, Allison Chunyk, Heather Thomas, Allison Naumovski, Steven R. Lentz

Blood (2023) 142 (Supplement 1): 5520.

https://doi.org/10.1182/blood-2023-179305

Published: 2023

Journal Articles

The Identification and Characterization of Retrospective Cohorts of Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Patients in the United States

Catherine Broome, Joseph Patrick Catlett, Daniel J Hausrath, Rahul Shah, Jacob Lai, Kathy Dong, Jon Fryzek, Meghan Mitchell, Lauren Bylsma, Loren Lipworth, Todd Edwards, Nawar Shara, Stephen Fernandez, Naval Daver, Carl E Allen

Blood (2023) 142 (Supplement 1): 5357.

https://doi.org/10.1182/blood-2023-180249

Published: 2023

Journal Articles

Incidence and Management of COVID-19 Infections in Vaccinated Patients with CLL

Blood (2023) 142 (Supplement 1): 5149.

https://doi.org/10.1182/blood-2023-173992

Published: 2023

Journal Articles

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

David J. Kuter, MD DPhil, Richy Agajanian, MD, Donald M. Arnold, MD MSc, FRCPC, Michael Boxer, MD, Catherine Broome, MD, Joshua J. Field, MD, Irina Murakhovskaya, MD, Kerry A. Rogers, MD, Ann M Lowe, MD, Sandra Tong, MD, Hany Zayed, PhD, Anne-Marie Duliege, MD MS

Blood (2018) 132 (Supplement 1): 3612.

https://doi.org/10.1182/blood-2018-99-110483

Published: 2018

Journal Articles

Incidence of Thromboembolic Events Is Increased in a Retrospective Analysis of a Large Cold Agglutinin Disease (CAD) Cohort

Catherine Broome, MD, Julia M Cunningham, MD, Megan Mullins, MPH, Xiaohui Jiang, MS, Lauren Bylsma, MPH, Jon Fryzek, MPH, PhD, Adam Rosenthal, PhD

Blood (2017) 130 (Supplement 1): 928.

https://doi.org/10.1182/blood.V130.Suppl_1.928.928

Published: 2017

Journal Articles

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of HLA Mismatched Platelets in a Transfusion Refractory Alloimmunized Patient: A Case Report

Maryam Sarraf Yazdy, MD, Catherine Broome, MD

Blood (2017) 130 (Supplement 1): 4845.

https://doi.org/10.1182/blood.V130.Suppl_1.4845.4845

Published: 2017

Journal Articles

Outcomes for Atypical Hemolytic Uremic Syndrome (aHUS) Treated with Eculizumab: A Single Center Analysis

Julia M Cunningham, MD, Jaeil Ahn, PhD, Catherine Broome, MD

Blood (2017) 130 (Supplement 1): 2331.

https://doi.org/10.1182/blood.V130.Suppl_1.2331.2331

Published: 2017

Journal Articles

Management of Catastrophic Antiphosphopholipid Syndrome with Eculizumab

Ami Chitalia, MD, David Swoboda, MD, Catherine Broome, MD

Blood (2016) 128 (22): 2603.

https://doi.org/10.1182/blood.V128.22.2603.2603

Published: 2016

Journal Articles

Presentation and Time to Treatment of Atypical Hemolytic Uremic Syndrome Is Influenced By Complement Amplifying Conditions: A Single Center Experience

Julia M Cunningham, MD, Jimmy Wang, PhD, Catherine Broome, MD

Blood (2016) 128 (22): 2543.

https://doi.org/10.1182/blood.V128.22.2543.2543

Published: 2016

Journal Articles

Complement Blockade with C1 Esterase Inhibitor in Severe C3d Positive Autoimmune Hemolytic Anemia

Jasmin Desai, MD, Catherine Broome, MD

Blood (2016) 128 (22): 4817.

https://doi.org/10.1182/blood.V128.22.4817.4817

Published: 2016

Journal Articles

Relapsing Thrombotic Thrombocytopenic Purpura: A Single Center Experience

Arielle L Heeke, MD, Craig M. Kessler, MD, Catherine Broome, MD

Blood (2016) 128 (22): 3732.

https://doi.org/10.1182/blood.V128.22.3732.3732

Published: 2016

Journal Articles

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of Antigen Mismatched Packed Red Blood Cells : A Case Report

Eiran Warner, MD BA, Catherine Broome, MD

Blood (2016) 128 (22): 3843.

https://doi.org/10.1182/blood.V128.22.3843.3843

Published: 2016

Journal Articles

A Case Series of Non-Hodgkin's Lymphoma Recurrence in Lower Extremities Mimicking Deep Vein Thrombosis

Shelly Ann Christiansen, MD, Philip Cohen, MD, Catherine Broome, MD

Blood (2016) 128 (22): 5344.

https://doi.org/10.1182/blood.V128.22.5344.5344

Published: 2016

Journal Articles

Complement Regulatory Gene Mutations in Non-Renal Solid Organ Transplant Recipients with Post-Transplant Thrombotic Microangiopathy

Kruti Sheth, MD, Raffaele Girlanda, MD, Catherine Broome, MD

Blood (2015) 126 (23): 3463.

https://doi.org/10.1182/blood.V126.23.3463.3463

Published: 2015

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Trial in progress: A phase 1b, open-label, multiple ascending dose study of OM336, a novel BCMAxCD3 T cell engager, in patients with relapsed/refractory autoimmune cytopenias (NCT07083960)

Long-term efficacy and safety of rilzabrutinib, an oral bruton tyrosine kinase (BTK) inhibitor in patients with warm autoimmune hemolytic anemia (wAIHA) in the LUMINA Phase 2b part B study: A 74-week follow-up

The safety and efficacy of pirtobrutinib in adults with immune thrombocytopenia: A phase 1/2 dose-finding study in progress

Sustained improvements in patient-reported outcomes after intravenous efgartigimod in adults with primary immune thrombocytopenia in a Phase 3 clinical trial (ADVANCE IV) and the first 52 weeks in its open-label extension study (ADVANCE IV+)

Survival outcomes of patients with secondary hemophagocytic lymphohistiocytosis at two academic medical centers in the United States

Real-world safety of sutimlimab in patients with CAD/CAS: A multinational, multi-center, observational, prospective cohort Study

Initial Report of Povetacicept, an Enhanced Dual BAFF/APRIL Antagonist, in Autoimmune Cytopenias: The RUBY-4 Study

The Identification and Characterization of Retrospective Cohorts of Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Patients in the United States

Incidence and Management of COVID-19 Infections in Vaccinated Patients with CLL

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

Incidence of Thromboembolic Events Is Increased in a Retrospective Analysis of a Large Cold Agglutinin Disease (CAD) Cohort

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of HLA Mismatched Platelets in a Transfusion Refractory Alloimmunized Patient: A Case Report

Outcomes for Atypical Hemolytic Uremic Syndrome (aHUS) Treated with Eculizumab: A Single Center Analysis

Management of Catastrophic Antiphosphopholipid Syndrome with Eculizumab

Presentation and Time to Treatment of Atypical Hemolytic Uremic Syndrome Is Influenced By Complement Amplifying Conditions: A Single Center Experience

Complement Blockade with C1 Esterase Inhibitor in Severe C3d Positive Autoimmune Hemolytic Anemia

Relapsing Thrombotic Thrombocytopenic Purpura: A Single Center Experience

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of Antigen Mismatched Packed Red Blood Cells : A Case Report

A Case Series of Non-Hodgkin's Lymphoma Recurrence in Lower Extremities Mimicking Deep Vein Thrombosis

Complement Regulatory Gene Mutations in Non-Renal Solid Organ Transplant Recipients with Post-Transplant Thrombotic Microangiopathy

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only